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Abstract: Th e aim of the study was to evaluate level of anxiety, depression and aggression and the sleep 
quality among Polish adolescent and young adult suff ering from cystic fi brosis including the evaluation 
of their FEV1.
Th e study involved 70 patients both male and female aged between 14 and 25 and suff ering from cystic 
fi brosis. Anxiety, depression and aggression were evaluated by means of Hospital Anxiety and Depression 
Scale and the quality of sleep was examined following Athens Insomnia Scale another aspect taken into 
consideration was patients’ FEV1. Th e data analysis was carried out by means of Chi2, Kolmogorov-
Smirnov test, Student’s t-test, Fisher-Snedecor test, Pearson correlation coeffi  cient. Th e level of statistical 
signifi cance was set at p <0.05.
Anxiety was observed in 27 (38.6%) cases, depression in 17 (24.3%) and aggression in 46 (65.7%) cases. 
Anxiety (p = 0.017) and aggression (p = 0.004) were signifi cantly higher among women than among 
men. 37 (52.8%) patients reported sleep disorders. Th e fi ndings proved that there is a connection between 
the quality of sleep and anxiety (r = 0.631; p = 0.000), depression (r = 0.621; p = 0.000) and aggression 
(r = 0.293; p = 0.014). No signifi cant relationship was found between the quality of sleep and patients’ 
expiratory volume.
Emotional disorders such as anxiety, depression and aggression as well as sleep disorders are commonly 
reported in patients suff ering from cystic fi brosis.
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Introduction
Cystic Fibrosis — CF is an incurable disease, which prematurely shortens human life. 
In Poland the occurrence of the disease is estimated at 1:2300–1:5200, which means 
that the number of patients who suff er from cystic fi brosis reaches 1500–2000 people 
and their life expectancy hovers around 22 years [1, 2]. Th e data is not precise because 
the Polish register of patients suff ering from cystic fi brosis run by the Polish Cystic 
Fibrosis Society has been suspended for about 3 years.
Th e fact that the life expectancy of cystic fi brosis patients was prolonged resulted 
in a  change of attitude towards the disease, which is no longer considered to be 
a  problem which affects only children. Current statistical data confirms that the 
number of adult patients suff ering from this chronic disease has been rising over the 
last few years and 50% of cystic fi brosis patients have a chance to live until the age of 
30 [3]. Th e increase in the survival outcomes is followed by higher responsibility for 
proper treatment control, enhancing effi  ciency of medical treatment and minimalizing 
the negative impact of the disease [4].
Cystic fi brosis leads to negative changes in most body organs, which results in 
a  drastic deterioration of the quality of life [5–9]. Th is fact is extremely important 
because the evaluation of quality of life is more and more frequently a part of routine 
clinical tests and is used by medical teams to develop and introduce the optimal 
plan of medical care and treatment, to understand patients’ emotions and to involve 
them in the diagnostic and therapeutic process. It has been proved by numerous 
publications in scientifi c papers concerning the connection between emotional state 
and the quality of life of chronic patients including those suff ering from cystic fi brosis 
[10–15]. Due to high risk of emotional disorders in CF patients, it is essential to 
pay more attention to health aspects diff erent from clinical ones, including being 
in pain, the quality of sleep and the level of aggressive, anxious and depressive 
behaviour, because they may have a  direct or indirect infl uence on life satisfaction. 
Th e occurrence or exacerbation of the symptoms mentioned above is connected with 
worse prognosis and worse functioning in many aspects of life, especially for young 
people [14, 16].
Young people have to take on new roles determined by human development and 
acquire various new abilities and this process might take place in an undisturbed way 
only if the proper balance is kept between internal and external factors infl uencing 
young people’s lives. In the case of cystic fibrosis, which, because of its clinical 
picture and shortened life expectancy, might evoke negative emotions, it is vital to 
fi nd out more about psycho-emotional state of patients and make them involved in 
the treatment process. Th e evaluation of quality of life including the factors which 
determine it is the best way to develop and choose the best holistic plan of providing 
care to the patient [14, 17, 18].
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Th e aim of the research was the evaluation of the incidence of anxiety, depression 
and aggression as well as the quality of sleep in adolescent and young adult patients 
including the evaluation of their FEV1.
Material and Methods
Th e research was carried out in 2016 in the National Tuberculosis and Lung Disease 
Research Institute in Rabka-Zdrój and among the patients of the Polish Society of 
Cystic Fibrosis Treatment. As many as 70 cystic fi brosis patients of both sexes aged 
between 14 and 25 participated in the research.
Th e Bioethics Committee of Jagiellonian University in Cracow approved of the 
research (Nr.122.6120.275.2015) and so did the Departmental Head of the Institute 
in Rabka-Zdrój and Managing Director of the Polish Society of Cystic Fibrosis 
Treatment. Th e research was carried out following the appropriate legal rules and 
bioethical principles of the Declaration of Helsinki.
Th e participants of the research were divided into 3 age groups: group I (aged 
14–16), group II (aged 17–20) and group III (aged 21–25). Th e groups refl ected the 
division applied currently in Polish education system and indicated the stages of 
junior high school, high school and university. Th e groups were created in such a way 
in order to determine patient’s emotional state in a  more precise way taking into 
consideration their present circumstances.
Participation in the research was voluntary and patients’ security and protection of 
their personal data were ensured. Patients were allowed to resign from the study at any 
stage. Th e participants of the study had to meet the following requirements: in the case 
of adolescents aged between 14 and 18 a verbal consent for voluntary participation in 
the study of one or both of their parents was required; a verbal consent for voluntary 
participation in the study was required from all adolescents and young adults aged 
between 14 and 25; clinical diagnosis if cystic fi brosis without other disorders or 
defects not resulting from the nature of the disease; lack of accompanying diagnosed 
psycho-emotional disorders; lack of diffi  cult external circumstances (separation, death 
in patient’s family, diffi  cult circumstances).
Th e research involved a diagnostic poll method: direct or CAWI (Computer-Assisted 
Web Interview) as well as the analysis of medical records. Th e evaluation of anxiety, 
depression and aggression intensity was carried out with the application of HADS 
(Hospital Anxiety and Depression Scale) [19, 20]. Th is diagnostic tool consists of 
7 questions evaluating anxiety, 7 questions evaluating depression and 2 questions 
evaluating aggression/irritability. Th e responses are scored on Likert scale within the 
range of 0–3 points. Th en the scores are added. Th e results referring to the anxiety 
and depression scale are interpreted according to the following categories: 0–7 points: 
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no disorders / low level of anxiety/depression, 8–10 points: borderline, middle level of 
anxiety/depression, 11–21 points: disorders, high level of anxiety/depression. As far as 
aggression (irritability) is concerned: 0–2 points: low level of aggression, 3–4 points: 
middle level of aggression, 5–6 points: high level of aggression.
Th e quality of sleep was evaluated with the application of AIS (Athens Insomnia 
Scale) adapted to Polish conditions [21, 22]. Th e scale consists of 8 questions which 
allow for evaluation of insomnia symptoms. Th e responses are scored within the range 
of 0 to 3 points. Th e maximum number of points totals 24. Th e results are interpreted 
according to 3 score categories: 0–5 points: no disorders, 6–10 points: borderline, 
11–24 points: insomnia.
Basic respiratory parameters —  FEV1 from the last 2 weeks were obtained 
from patient’s medical records. Pulmonary disease was considered mild for values 
over 70%, moderate for values between 40% and 70%, and severe for values under 
40% [9].
In the fi ndings analysis the values of quality variables were presented by means 
of absolute values and percentages and the diff erences within particular groups were 
examined by Chi2 test. Th e values of quantity variables were presented by means of 
the mean (X) and standard deviation (SD). In order to choose appropriate statistical 
methods a  comparison of the analysed data distribution and a  regular distribution 
was carried out by means of Kolmogorov-Smirnov test.
The relationships between quantity variables within particular groups were 
examined by means of Student’s t-test for independent groups in the case of groups 
with regular distribution or unifactorial analysis of variance ANOVA, whereas 
the relationships between particular groups were studied by means of appropriate 
post-hoc tests. In order to evaluate the strength and direction of a  relationship 
between particular quantity variables r-Pearson correlation coefficient was used 
for variables with regular distribution. Th e level of statistical signifi cance was set 
at p <0.05.
Results
Sociodemographic and clinical data
Th e research was carried out in a  group consisting of 30 (42.9%) women and 
40  (57.1%) men. Th ere were 18 (25.7%) people in group I (aged between 14 and 
16), 23 (32.9%) people in group II (aged between 17 and 20) and 29 (41.4%) people 
in group III (aged between 21 and 25). Th irty-seven (52.9%) patients lived in the 
country, 19 (27.1%) patients in a  city with the population below 100,000 and the 
remaining 14 (20%) patients in a city with the population above 100,000.
Th e evaluation of weight and height essential for calculating patients’ BMI showed 
that among the cystic fi brosis patients in age group I as many as 10 (14.3%) patients 
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were underweight —  BMI below 18.5. In age group II BMI was lower than 18.5 in 
the case of 11 (15.7%) patients. Whereas in group III only 4 (5.7%) patients were 
underweight. 
Th e analysis of FEV1 parameter (Table 1) proved that 10 (14.3%) patients had 
a  severe stage of bronchopulmonary disease, 30 (42.9%) patients were reported to 
have a moderate stage and further 30 (42.9%) patients were reported to have an early 
stage of the disease. 
Statistical analysis confi rmed that there is a  signifi cant diff erence among cystic 
fi brosis patients in the level of expiratory volume, i.e. the stage of bronchopulmonary 
disease: Chi2 = 11.43; p = 0.003.
Th ere was no correlation between the stage of bronchopulmonary disease and 
patients’ sex (Chi2 = 0.856; p = 0.652) or age (Chi2 = 2.057; p = 0.725).
Table 1. Th e relation between patients’ expiratory volume (FEV1) and sex and age group. 
FEV1 (%) Sex n (%) Age group n (%)
>70 (n = 30)





10 (14.7)M 17 (24.3)
<70 and > 40 (n = 30)





15 (21.4)M 16 (22.9)
<40 (n = 10)





4 (5.7)M 7 (10.0)
Total 70 (100) 70 (100)
F = female; M = male; n = number of people
Evaluation of patients’ emotional state by means of HADS
Evaluation of selected emotional states (anxiety, depression, aggression) proved the 
incidence of anxiety in 27 (38.6%) patients, depression in 17 (24.3%) patients and 
aggression in 46 (65.7%) patients. Th e sum of the results does not total to 100 because 
some patients experienced more than one negative emotional state. Detailed results of 
the analysis of emotional states are presented in Table 2.
Th e distribution of incidence of the emotional states examined divided according 
to patients’ sex proved to be comparable. Anxiety was experienced by 14 (51.9%) 
women and 13 (48.1%) men. Th e feeling of depression appeared in 9 (53%) women 
and 8 (47%) men, whereas aggression (irritability) was experienced by 23 (50%) 
patients both women and men. 
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Table 2. Evaluation of anxiety, depression and aggression incidence in the examined group of patients.
Emotional state HADS scores Category n (%) Chi² P-value
Anxiety 
(n = 27)
 8–10 Borderline results 13 (48.1)
0.037 0.847
11–21 Anxiety disorders 14 (51.9)
Depression 
(n = 17)
 8–10 Borderline results 12 (70.6)
0.154 0.695
11–21 Depressive disorders 5 (29.4)
Aggression 
(n = 46)
 3–4 Borderline results 32 (69.6)
7.043 0.008*
 5–6 Aggression disorders 14 (30.4)
*statistically signifi cant; n = number of people
Table 3. Testing the signifi cance of diff erences in the emotional state levels in female (n = 30) and male 
(n = 40) patients suff ering from cystic fi brosis.
Variable Sex X ± SD t-test P-value
Anxiety
F 7.8 ± 4.2
2.443 0.017*
M 5.3 ± 4.2
Depression
F 4.7 ± 3.5
0.719 0.474
M 4.1 ± 3.9
Aggression
F 3.9 ± 1.5
2.988 0.004*
M 2.9 ± 1.4
*statistically signifi cant; F = female; M = male
Table 4. Testing the signifi cance of diff erences in the emotional state levels in patients suff ering from 
cystic fi brosis according to their age. 
Variable Age X ± SD F P-value
Anxiety
from 14 to 16 6.2 ± 5.1
0.611 0.546from 17 to 20 7.2 ± 4.2
from 21 to 25 5.8 ± 4.1
Depression
from 14 to 16 3.4 ± 3.9
1.618 0.205from 17 to 20 5.4 ± 3.6
from 21 to 25 4.1 ± 3.7
Aggression
from 14 to 16 3.5 ± 1.5
0.427 0.654from 17 to 20 3.1 ± 1.4
from 21 to 25 3.4 ± 1.7
 Emotional states and sleep disorders in adolescent and young adult... 33
Statistical analysis did not prove a  significant relation between depression 
and patients’ sex as opposed to anxiety and aggression. Both the level of anxiety 
and the level of depression were significantly higher in women than in men 
(Table 3).
Moreover, statistical tests did not confirm a  statistically significant relation 
between anxiety, depression, aggression and patients’ age (Table 4).
Evaluation of the quality of sleep by means of AIS
Evaluation of the quality of sleep showed that 37 (52.8%) cystic fi brosis patients 
reported sleep disorders: 15 (21.4%) patients complained of insomnia and borderline 
condition was diagnosed in 22 (31.4%) patients. A statistically signifi cant diff erence in 
the patients’ quality of sleep was observed (Chi2 = 7.06; p = 0.029). 
Evaluation of the relation between particular emotional states 
and the quality of sleep taking into consideration patients’ sex 
Statistical analysis proved that in the group of people reporting anxiety 23 (85.2%) 
patients suff ered from sleep disorders (borderline:12; 52.2%, insomnia: 11; 47.8%) as 
well, whereas in the group of depressive patients sleep disorders (borderline: 6; 42.9%, 
insomnia: 8; 57.1%) appeared in 14 (82.4%) patients. In the case of respondents with 
irritability (aggression) symptoms sleep disorders (borderline: 16; 55.2%, insomnia: 
13; 44.8%) occurred in 29 (63%) patients. 
In order to verify the relation between anxiety, depression, aggression and the 
quality of sleep r-Pearson correlation coeffi  cient was calculated. Statistical analysis 
proved that anxiety, depression and aggression in cystic fibrosis patients have 
a signifi cant infl uence on their quality of sleep (Table 5).
Table 5. Testing the relation between emotional states and the quality of sleep in patients suff ering from 
cystic fi brosis.
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Anxiety disorders accompanied by sleep disorders were diagnosed in 52.2% of 
women and 47.8% of men, depressive disorders with accompanying sleep disorders 
were reported in 42.9% of women and 57.1% of men whereas aggression (irritability) 
accompanied by sleep disorders appeared in 48.3% of women and 51.7% of men. 
Th e mean values of AIS were not signifi cantly diff erent between men and women 
(8.3 ± 5.1 vs 6.5 ± 5.1; t = 1.458; p = 0.149).
Evaluation of relation between patients’ expiratory volume 
and their quality of sleep 
In the group of patients diagnosed with bronchopulmonary in its early stage 
19 (27.1%) patients reported sleep disorders. In the group with the moderate stage of 
the disease sleep disorders were reported by 11 (15.7%) patients, whereas in the group 
with severe stage of the disease 7 (10%) patients complained of problems with sleep. 
Statistical analysis which followed did not prove a  signifi cant infl uence of expiratory 
volume on the quality of sleep (r = 0.187; t = 1.566; p = 0.122). 
Discussion
With a growing number of adolescents and adults suff ering from cystic fi brosis there 
arises the need to pay more attention to patients’ emotions and psychological sphere 
[23–26] and fi ndings obtained from studies into this fi eld may prove to be vital in 
minimalising the negative impact of the disease and maximizing the effi  ciency of 
medical treatment.
Th e key to achieve the main objective of the research was an attempt to evaluate 
patients’ disorders in emotional sphere taking into consideration variables such as 
anxiety, depression, aggression (irritability) and the quality of sleep. Th e fi ndings 
obtained in the individual study indicate a higher number of cystic fi brosis patients 
who were not diagnosed with anxiety and depressive disorders. Aggression (irritability) 
was identifi ed in half of the patients. Th e level of anxiety and depression turned out 
to be the same in the 17–20 age group and the 21–25 age group. Th e highest level 
of aggression was identifi ed in the 21–25 age group. Th e same level of anxiety and 
depression in the 17–20 age group and the 21–25 age group may mean both higher 
emotional awareness and the awareness of the consequences of the disease but also 
they may mean psycho-emotional maturity or accepting the circumstances determined 
by a particular health condition. Just as in the individual research, Harning et al. [12] 
also carried out an analysis of the incidence of anxiety and depression pointing out 
that the incidence of the emotions in question was not remarkably widespread among 
the patients. Similar results were obtained by Oliveiry’s team [13], which also did 
not diagnose anxiety and depression in the majority of cases but discovered a close 
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relationship between negative emotional states and deteriorated quality of patients’ 
lives. It is worth pointing out that the study was carried out in a  group of adult 
patients. Another example of the research with results comparable to the results of the 
individual research was the one carried out by Quittner et al. [27], the authors of one 
of the biggest screening among teenagers suff ering from cystic fi brosis, who proved 
the relationship between the incidence of anxiety or depression and patient’s sex. In 
the research carried out by the Macedonian Academy of Science and Arts [28] cystic 
fi brosis patients were diagnosed with a  moderate level of anxiety but a  high level 
of depression and aggression, however, the evaluation of emotional state comprised 
only a narrow age group of patients (13–15) and involved the application of the scale 
adapted for this age group, which might have been the reason of diff erent results. Th e 
age group examined is the age of adolescence and therefore the period of teenage 
rebellion, which may account for a high level of aggression among respondents.
Th e study carried out by Goldbeck et al. [29] took into account a wide range of 
patients’ age. Similarly to the individual research, the authors’ evaluation of patients’ 
emotional state by means of HADS proved that in the majority of cases the level of 
anxiety and depression was normal. Anxiety was the most common in the 12–20 age 
group and depression, in turn, prevailed among patients aged between 21 and 30. It 
is worth pointing out that Goldbeck et al. applied diff erent age groups in comparison 
to the individual research. Th e incidence of anxiety among patients aged between 12 
and 20 may be accounted for by an increasing range of responsibilities which young 
people must take on, whereas a  high level of depression in the 21–30 age group 
might be caused by the diffi  culties related to reaching adulthood. Th e results of the 
fi ndings quoted above can be considered reliable because they refer to a  diverse 
group of patients. Although the research did not confi rm the incidence of depression 
in a signifi cant number of patients, more attention should be paid to the risk which 
is posed by the incidence of anxiety. A potential threat that patients experiencing 
anxiety will in the future develop depressive disorders or even depression itself cannot 
be ruled out. Anxiety and depression may overwhelmingly dominate the quality of 
life of these patients, and thus, shorten their life.
Cystic fi brosis is a  disease which prematurely shortens patients’ life expectancy, 
it develops involving various stages of exacerbation and may impede patient’s 
functioning in the society, which provokes negative emotions in young patients. 
Adolescence and reaching maturity is the time of numerous changes in the life of 
young people. The disease makes both women and men face extremely difficult 
circumstances, which provokes extreme emotions. Th e diff erences between the sexes 
are not only physical ones but, above all, they involve psychological divergence. 
Patients’ sex determines their reactions and the way they deal with the disease, which 
was proved by the fi ndings of the study mentioned above. When patients’ sex is taken 
into consideration, the level of anxiety and aggression was higher in women than in 
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men. Statistical analysis did not prove a  statistically signifi cant diff erence between 
the incidence of depression and patients’ sex. In the study carried out by Backström-
Eriksson et al. [30] in the group of cystic fi brosis patients in Sweden and the United 
Kingdom, the authors noticed that there was a diff erence in the frequency of anxiety 
and depression incidence in women and men, pointing out that the level of anxiety 
was higher in women than in men. However, even though Backström-Eriksson 
et al. applied HADS, they excluded the part which evaluated aggression (irritability), 
which made it impossible to compare their results in this area with the results of the 
individual study. Th e fact that the comparably high level of anxiety was detected in 
countries with diff erent cultural background (in Poland as well as in Sweden and the 
United Kingdom) indicates a strong relation between cystic fi brosis patients’ sex and 
this emotional state.
Moreover, the evaluation of negative emotional states in patients outside the cystic 
fi brosis group seems to confi rm the relation between anxiety and depression and 
patients’ sex [31]. Further research in this fi eld may be an important source for future 
analyses both for psychologists and health care professionals.
Th e attempt to recognize and understand the causes of the problem and carrying 
out further research into this field may have a  significant impact on the proper 
diagnosis of negative emotional states in the patients and help to improve their 
health condition. Screening test, which detect negative emotional states, for example, 
application of HADS, seem to be both advisable and necessary because of their direct 
infl uence on the quality of life and life expectancy. Negative emotional states may be 
a signifi cant factor responsible for the progress of the disease [32] and life expectancy 
[33]. HADS seems to be a useful screening tool because it can be applied not only by 
psychologists but also by doctors and nursing teams. 
The quality of sleep is another essential factor in the case of cystic fibrosis 
patients. Appropriate sleep hygiene is important for young organisms. Sleep allows 
for proper regeneration, determines healthy growth, infl uences the progress of the 
disease and patient’s psychophysical functioning understood in a  broad sense. Bad 
quality of sleep is connected with an increased risk of the incidence of anxiety and 
depression [34]. Th e individual research proved that almost a half of the respondents 
had problems with sleep. Th is group consisted of both borderline patients and those 
reporting insomnia symptoms. Th e research did not prove the relation between the 
quality of sleep and expiratory volume. However, it must be pointed out that patients 
with acute respiratory failure, poor general condition and those treated permanently 
with oxygen therapy or undergoing mechanical ventilation did not participate in the 
research. Scientifi c fi ndings and the results of the individual study of cystic fi brosis 
patients’ sleep show a  relation between the quality of sleep and various spheres of 
patients’ life and their functioning [16, 35–40]. Th e results obtained unambiguously 
point out a  high percentage of patients who suff er from sleep disorders of various 
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origins (e.g. obstructive sleep apnoea, delayed sleep, frequent waking up, respiratory 
disorders). Although the individual research did not prove a  signifi cant infl uence 
of lung functioning on the quality of sleep, it cannot be ruled out that this relation 
will not be discovered if another group of patients is examined or if the research 
is more extensive. Also the infl uence of factors diff erent from the analysed ones 
cannot be excluded. Th e research described above might have been limited as well 
by a  low number of participants. Continuation of research into human psycho-
emotional sphere, quality of life and relations between various factors determining 
psychophysical and social functioning of cystic fi brosis patients might, in the future, 
be a  vital issue which would improve standards of medical care and determine the 
patients’ life expectancy. 
Conclusions
Women experienced a  higher level of anxiety and a  higher level of aggression than 
men. No statistically signifi cant relation was found between depression and patients’ 
sex.
Most cystic fi brosis patients, regardless of their sex, complained of sleep disorders. 
Emotional state disorders have a  signifi cant infl uence on the quality of sleep. Along 
with an increase in the level of anxiety, depression and aggression, there increases 
a likelihood of sleep disorders. 
No statistically signifi cant relation was found between the quality of sleep and the 
stage of a bronchopulmonary disease progress in the examined group of patients. 
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